Guardion Health Sciences Regains Compliance with Nasdaq Minimum Bid Price Rule
16 mars 2021 08h00 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
11 mars 2021 08h00 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Announces 1-for-6 Reverse Stock Split Effective Pre-Market Opening on Monday, March 1, 2021
26 févr. 2021 08h00 HE
|
Guardion Health Sciences, Inc.
Recent at-the-market financings and warrant exercises have netted a combined $37.2 million in 2021, providing an effective cash runway for program execution and acquisition strategy implementation ...
Malaysia’s Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences
28 janv. 2021 16h15 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule
27 janv. 2021 08h30 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer
28 déc. 2020 16h20 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V
16 déc. 2020 08h00 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2020
12 nov. 2020 16h05 HE
|
Guardion Health Sciences, Inc.
Guardion Also Provides Corporate Update SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company...
Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardion’s Proprietary Lumega-Z® Formulation Compared to AREDS-2 Formulation
28 oct. 2020 08h30 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Health Sciences Announces Investigator-Initiated Clinical Trial of Lumega-Z
26 oct. 2020 08h00 HE
|
Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...